Story
FICO Options Market Flashes Bearish Signals After Regulatory Setback

Summary
Options traders are placing significant bearish wagers on Fair Isaac Corp. after a U.S. regulatory decision opened its lucrative mortgage-scoring business to competition, sending the stock to a 52-week low.
Significant options activity in Fair Isaac Corp. (NYSE: FICO) indicates traders are betting on further declines after a major regulatory decision threatened the company's dominance in the U.S. mortgage market. The credit scoring firm's stock fell more than 5% to a 52-week low of $586.05 on Monday as investors digested the news.
The Catalyst and Options Flow
The sell-off was triggered by a decision from the Federal Housing Finance Agency (FHFA) to place VantageScore 4.0 on an equal pricing grid with the classic FICO score for mortgage loans. This move effectively dismantles the regulatory protection that has long secured FICO's near-monopoly in the conforming mortgage market.
In response, options traders have shown a distinct bearish bias, according to market data from Monday afternoon:
- Put Volume: Put contract volume surged to 2,966, its highest level since October 2025.
- Put/Call Ratio: The ratio of puts to calls stood at 1.12, indicating a higher demand for bearish options.
- Key Trade: A notable trade involved 525 contracts of the November 20, 2026, $500 put. With open interest at just 71, this suggests a large, new position betting the stock will fall another 15% from its current levels.
Market Impact
AdFICO shares were trading at $586.75 late Monday, a decline of 5.04% for the session. The stock is now down 65.3% year-to-date, reflecting severe market concern over the long-term impact of increased competition.
Interestingly, while traders are placing bearish bets, other market indicators suggest the initial shock may be subsiding. Three-month implied volatility, a measure of expected price swings, has eased, and the options skew—the price difference between bearish puts and bullish calls—has collapsed to nearly flat. This signals that the market may have already priced in a significant amount of the negative news, viewing future risk as more balanced.
Wall Street Divided
Analysts are sharply divided on FICO's prospects, highlighting the profound uncertainty facing the company. Bank of America downgraded the stock to Neutral and slashed its price target in half to $700 from $1,400, citing risks to FICO's pricing power.
In contrast, Jefferies maintained a Buy rating with a $1,675 price target. While acknowledging that VantageScore could capture up to 80% of the conforming mortgage market, the firm's analysis appears to see a path forward for FICO. This wide spread in price targets underscores the central debate: whether FICO's business model is fundamentally broken or simply facing a significant but manageable challenge.
Read next
More on Stocks
US Transportation Secretary Pushes to Expedite Aircraft Certification Amid China Competition Concerns
Transportation Secretary Sean Duffy stated the U.S. must speed up its aircraft approval process to maintain a competitive edge against China and encourage private investment in aviation innovation. The move follows existing FAA efforts to modernize certification.

Jefferies Identifies Three Biotech Firms with Blockbuster Drug Potential
Investment firm Jefferies has highlighted Delphia Therapeutics, Axsome Therapeutics, and BridgeBio Pharma as undervalued biotech companies with strong late-stage pipelines and significant commercial prospects.

Synopsys Shares Rise on OpenAI Partnership and Strong Revenue Forecast
Chip design software leader Synopsys is partnering with OpenAI on a revenue-sharing basis to develop a specialized AI model for semiconductor design, a move that boosted its stock and financial outlook.

Jefferies Initiates Coverage on Molbio Diagnostics with 'Buy' Rating
Jefferies has initiated coverage on Molbio Diagnostics, naming it a top pick in India's medical supplies sector with a 'Buy' rating and a price target of INR 1,600, citing the strength of its point-of-care diagnostics platform.